Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ADMP Financial Statements and Analysis

NASDAQ : ADMP

Adamis Pharmaceuticals Corporation

$0.78
0.0065+0.85%
At Close 4:00 PM
Not Actively Trading
57.67
BESG ScoreESG Rating

ADMP FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ADMP Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2023-09-302023-06-302023-03-312022-12-312022-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202320222022
periodQ3Q2Q1Q4Q3
revenue9.062M6.945K1.453M2.151M1.506M
cost of revenue0361.394K1.788M2.482M1.648M
gross profit9.062M-354.449K-335.066K-331.107K-141.902K
gross profit ratio1.00-51.037-0.231-0.154-0.094
research and development expenses418.518K376.957K1.311M859.846K1.978M
general and administrative expenses04.033M000
selling and marketing expenses00000
selling general and administrative expenses2.517M4.033M4.782M3.151M2.508M
other expenses0463.018K-113.034K00
operating expenses2.936M4.41M6.093M4.011M4.486M
cost and expenses2.936M4.771M7.881M6.492M6.134M
interest income13.835K703.0011.00-318.44K298.118K
interest expense-29.465K46.312K2.587M-253.992K298.118K
depreciation and amortization087.349K2.583M-320.158K697.103K
ebitda-3.265M-4.213M-3.844M-4.662M-3.931M
ebitda ratio-0.36-606.684-2.646-2.168-2.611
operating income-3.265M-11.304M-6.428M-4.342M-4.628M
operating income ratio-0.36-1.628K-4.424-2.019-3.074
total other income expenses net3.613M-2.193M-2.587M940.751K356.808K
income before tax348.202K-7.003M-9.015M-3.401M-4.271M
income before tax ratio0.038-1.008K-6.204-1.581-2.837
income tax expense02.08M-9.086M2.00K127.692K
net income348.202K-8.574M71.701K-3.403M-4.399M
net income ratio0.038-1.235K0.049-1.582-2.922
eps0.049-3.340.033-1.59-2.05
eps diluted0.049-3.340.033-1.59-2.05
weighted average shs out7.066M2.569M2.185M2.143M2.143M
weighted average shs out dil7.066M2.569M2.185M2.143M2.143M
Graph

ADMP Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2023-09-302023-06-302023-03-312022-12-312022-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202320222022
periodQ3Q2Q1Q4Q3
cash and cash equivalents6.664B640.254K3.10M1.081M2.42M
short term investments00000
cash and short term investments6.664B640.254K3.10M1.081M2.42M
net receivables018.971K21.173K1.085M1.554M
inventory662.962M664.358K664.358K1.239M1.092M
other current assets545.178M658.119K750.272K893.928K803.415K
total current assets7.872B3.451M7.547M9.272M10.088M
property plant equipment net1.076B1.289M1.477M1.607M1.997M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets9.674M9.674K52.174K52.174K52.174K
total non current assets1.085B1.298M1.529M1.659M2.049M
other assets00000
total assets8.957B4.749M9.076M10.931M12.137M
account payables9.973B11.366M9.781M7.937M5.298M
short term debt63.209M157.246K250.361K342.562K368.809K
tax payables00000
deferred revenue172.779M174.897K27.779K27.779K27.779K
other current liabilities3.253B3.309M2.889M3.088M3.18M
total current liabilities13.462B15.007M12.949M11.396M8.874M
long term debt000063.209K
deferred revenue non current157.413M164.357K171.302K178.247K185.191K
deferred tax liabilities non current00000
other non current liabilities302.17M1.403M5.638M164.795K169.34K
total non current liabilities459.583M1.567M5.809M343.042K417.74K
other liabilities00000
capital lease obligations63.209M157.246K250.361K342.562K432.018K
total liabilities13.922B16.574M18.758M11.739M9.292M
preferred stock330.00M330.00K157.303K0157.303K
common stock1.01M15.831K15.051K15.051K15.051K
retained earnings-323.469B-322.081M-313.507M-304.564M-301.237M
accumulated other comprehensive income loss-330.00M-345.831K000
other total stockholders equity318.504B310.256M303.653M303.741M303.91M
total stockholders equity-4.965B-11.825M-9.682M-808.068K2.845M
total equity-4.965B-11.825M-9.682M-808.068K2.845M
total liabilities and stockholders equity8.957B4.749M9.076M10.931M12.137M
minority interest00000
total investments00000
total debt63.209M157.246K250.361K342.562K432.018K
net debt-6.601B-483.008K-2.849M-738.802K-1.988M
Graph

ADMP Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2023-09-302023-06-302023-03-312022-12-312022-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202320222022
periodQ3Q2Q1Q4Q3
deferred income tax0-3.908M000
stock based compensation052.198K69.294K-325.959K74.488K
change in working capital01.671M4.952M-988.014K-3.557M
accounts receivables001.054M252.447K-1.307M
inventory00574.42K-146.333K-681.25K
accounts payables01.194M1.778M2.614M787.242K
other working capital0476.172K1.546M-3.709M-2.356M
other non cash items08.104M2.264M2.747M-15.76K
net cash provided by operating activities0-2.569M-1.548M-1.522M-7.498M
investments in property plant and equipment000-91.494K-207.756K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites0138.291K841.778K246.796K986.976K
net cash used for investing activites0138.291K841.778K155.302K779.22K
debt repayment000-17.033K0
common stock issued000300.00K0
common stock repurchased00000
dividends paid00000
other financing activites002.724M-282.967K285.00K
net cash used provided by financing activities0750.002.724M284.715M285.00K
effect of forex changes on cash01.969M0-284.687M-22.096K
net change in cash0-2.46M2.018M-1.339M-6.456M
cash at end of period0670.344K3.13M1.111M2.45M
cash at beginning of period03.13M1.111M2.45M8.906M
operating cashflow0-2.569M-1.548M-1.522M-7.498M
capital expenditure000-91.494K-207.756K
free cash flow0-2.569M-1.548M-1.614M-7.706M
Graph

Frequently Asked Questions

How did Adamis Pharmaceuticals Corporation do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ADMP generated $9.06M in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Adamis Pharmaceuticals Corporation report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Adamis Pharmaceuticals Corporation reported a $9.06M Gross Profit for the quarter ended Sep 30, 2023.

Have ADMP's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ADMP incurred $2.94M worth of Operating Expenses, while it generated -$3.27M worth of Operating Income.

How much Net Income has ADMP posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Adamis Pharmaceuticals Corporation, the company generated $348.20K in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Adamis Pharmaceuticals Corporation have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Adamis Pharmaceuticals Corporation as of the end of the last quarter was $6.66B.

What are ADMP's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ADMP had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did Adamis Pharmaceuticals Corporation stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ADMP were $7.87B, while the Total Assets stand at $8.96B.

As of the last quarter, how much Total Debt did Adamis Pharmaceuticals Corporation have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ADMP's debt was $63.21M at the end of the last quarter.

What were ADMP's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ADMP reported total liabilities of $13.92B.

How much did ADMP's Working Capital change over the last quarter?

Working Capital Change for ADMP was $0.00 over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ADMP generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ADMP generated $0.00 of Cash from Operating Activities during its recently reported quarter.

What was ADMP's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ADMP reported a $0.00 Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph